Thus, the observation seems to be consistent with our previous report that TYK2 promoter variant was most likely associated with viral infections in diabetic patients dependent on defective type 1 IFN response (Nagafuchi et al., 2015), but not with Th2 immune response. Here, TYK2 is linked to viral infectious disease.